CSCI(Delisted)
Cosciens Biopharma·NASDAQ
--
--(--)
CSCI Filings
Filing Date
Form Description
Form Type
2025-12-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-14 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-08-26
Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Key Events
2025-08-26 · Key Events
Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025-08-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-08-14 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-08-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-08-14 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-11
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-06-11 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-06-09
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-09 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
